Accelerating Biologics Discovery & Development Through Transformative Technologies & Overcoming Strategic Challenges
A concise report featuring insights from the prominent thought leaders of Biologics 2024
Exploring Innovative Approaches Throughout the CGT Development Journey
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Cell UK
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Immuno-Oncology
Canopy Biosciences: Using the ROSALIND Platform to Accelerate Single-Cell Data Analysis
Single-Cell RNA-Sequencing CRO Service.
Biomarkers & Precision Medicine
ChemPartner: GPCR/Transporter/Ion Channel Screening
Overview of Capabilities.
Immunotherapy (Non-Oncology)
ChemPartner: Inflammation and Immunology
Specialize in primary immune cells with a full panel of assay format (in vitro and ex vivo) on cells from different species, providing multiple optional readouts.
Immuno-Oncology
ChemPartner: Tailored Drug Discovery & Development
ChemPartner has the capabilities and expertise to support the end to end drug discovery process across multiple modalities (illustrated below with the small molecule flow scheme). We support the process with expertise and resources at every stage in a fully managed and integrated manner.
Immuno-Oncology
Crown Bioscience: Discover the Infinite Power of Partnership
We are Crown Bioscience and this is where Innovation and Quality Transforms Scientific Discovery
Drug Discovery & Development
GD2 CAR-T cells engineered using retroviral transduction or CRISPR editing exhibit strong cytolytic potency against glioma stem cells
Axion BioSystems’ Maestro Z platform offers impedance-based cell analysis for real-time, label-free monitoring of cell viability, morphology, cytolysis, and signaling.